2021 American Society of Hematology Annual Meeting*

Download All
December 11-14, 2021; Atlanta, Georgia
Review slidesets and expert analyses of key studies from the 2021 Hematology Annual Meeting!
John M. Burke, MD
Amy E. DeZern, MD, MHS
Shaji K. Kumar, MD
Sagar Lonial, MD
Peter Martin, MD
Mark A. Schroeder, MD
Sujit Sheth, MD
B Douglas Smith
B. Douglas Smith, MD
Srdan Verstovsek, MD, PhD
Eunice S. Wang, MD

An Expert’s Guide to ASH 2021: A Preview of the Top Abstracts

Review experts’ perspectives on the most clinically relevant data on malignant and nonmalignant hematology to be presented at the ASH 2021 annual meeting, including key insights and the latest data you need to understand and integrate into your practice.

John M. Burke, MD Amy E. DeZern, MD, MHS Shaji K. Kumar, MD Sagar Lonial, MD Peter Martin, MD Mark A. Schroeder, MD Sujit Sheth, MD B Douglas Smith B. Douglas Smith, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Released: December 8, 2021

Acute and Chronic Leukemias

Lymphomas and Chronic Lymphocytic Leukemia

Multiple Myeloma

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
Daiichi Sankyo, Inc.
GlaxoSmithKline
Incyte Corporation
Jazz Pharmaceuticals, Inc.
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings